SCHEMBL1234932

SCHEMBL1234932

OCCCc1ccc(O)c(O)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 9/20 0.78
IGF1R P08069 7/20 0.78
MAPT P10636 4/20 0.75
KDM4E B2RXH2 3/20 0.75
ALDH1A1 P00352 2/20 0.75
GAA P10253 2/20 0.75
ALOX5 P09917 1/20 0.75
BACE1 P56817 1/20 0.75
MAPK1 P28482 3/20 0.59
ADRA2A P08913 2/20 0.59
DRD2 P14416 2/20 0.59
DRD1 P21728 2/20 0.59
DRD4 P21917 2/20 0.59
DRD5 P21918 2/20 0.59
SLC6A2 P23975 2/20 0.59
DRD3 P35462 2/20 0.59
RECQL P46063 2/20 0.59
SLC6A3 Q01959 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
TP53 P04637 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11424371 0.93 ALOX15 (0.83) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL10825972 0.91 ALOX15 (0.79) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL10826052 0.91 ALOX15 (0.79) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL10826102 0.91 ALOX15 (0.79) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL10824633 0.91 ALOX15 (0.79) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL2307446 0.88 ALOX15 (1.00) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL107170 0.88 ALOX15 (0.90) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL31556189 0.86 ALOX15 (0.95) ALOX15IGF1RMAPTKDM4EALDH1A1
SCHEMBL31556196 0.86 ALOX15 (0.95) ALOX15IGF1RMAPTKDM4EALDH1A1
Hydroxytyrosol SCHEMBL44363 0.86 MAPT (1.00) ALOX15IGF1RMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260102359-A1 COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION ERESINA LLC (US) 2026-04-16 US claimed
US-20260062554-A1 Stabilized Indigo Carmine Composition KINNOS INC (US) 2026-03-05 US claimed
EP-4694699-A2 COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY VitaKey Inc. (US) 2026-02-18 EP claimed
EP-4678018-A1 AN AEROSOL GENERATING MATERIAL Nicoventures Trading Limited (GB) 2026-01-14 EP claimed
EP-4678014-A1 AN AEROSOL GENERATING MATERIAL Nicoventures Trading Limited (GB) 2026-01-14 EP claimed
EP-4678019-A1 AN AEROSOL GENERATING MATERIAL Nicoventures Trading Limited (GB) 2026-01-14 EP claimed
EP-4618965-A1 NOVEL OPHTHALMIC FORMULATION Fertis India Pvt. Ltd. (IN) 2025-09-24 EP claimed
EP-4593859-A1 COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION Eresina, LLC (US) 2025-08-06 EP claimed
EP-4233858-B1 ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS OR PRECURSORS THEREOF AMAZENTIS SA (CH) 2025-02-12 EP claimed
WO-2024216228-A2 COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY VITAKEY INC. (US) 2024-10-17 WO claimed
US-20210130273-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIVERSITEIT ANTWERPEN (BE) 2021-05-06 US claimed
US-20200317593-A1 LIGNIN CONVERSION TO PHENOLIC MOLECULES USING TRANSITION METAL CATALYSTS SPERO RENEWABLES, LLC 2020-10-08 US claimed
CN-111642575-A Oily system containing 3, 4-dihydroxy phenethyl alcohol, preparation method and application 杭州唯铂莱生物科技有限公司 2020-09-11 CN claimed
EP-3661902-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS Universiteit Antwerpen (BE) 2020-06-10 EP claimed
CN-111233631-A Method for preparing 3, 4-dihydroxy phenethyl alcohol 辽宁东科药业有限公司 2020-06-05 CN claimed
CN-110038137-A A kind of CT visualization and the difunctional microcapsules of mucoadhesive type and preparation method and applications 天益健康科学研究院(镇江)有限公司 2019-07-23 CN claimed
WO-2019025535-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIVERSITEIT ANTWERPEN (BE) 2019-02-07 WO claimed
CN-109313120-A Humidity sensor and application thereof 吉林大学 2019-02-05 CN claimed
CN-104140546-B Method for preparing carbon nanotube-like degradable polymer 江南大学 2017-02-15 CN claimed
WO-2011022511-A2 METHODS OF REDUCING LIGNIN AND PRODUCTS THEREOF STRATEGIC ENZYME APPLICATIONS, INC. (US) 2011-02-24 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062554-A1 Stabilized Indigo Carmine Composition SOD1, SOD3, SCO2 ALOX15 1422/4885IGF1R 1042/4885MAPT 1545/4885
US-20260102359-A1 COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION COL2A1, COLGALT1, PLOD3 ALOX15 76/4885IGF1R 2820/4885MAPT 696/4885
US-20210130273-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS HAAO, TDO2, HPD ALOX15 1157/4885IGF1R 4798/4885MAPT 3337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.